Lantheus (NASDAQ:LNTH) PT Raised to $96.00 at Truist Financial

Lantheus (NASDAQ:LNTH – Get Free Report) had its price target hoisted by Truist Financial from $82.00 to $96.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s target price would suggest a potential upside of 27.10% from the company’s previous […]

Related Keywords

United States ,Boston ,Massachusetts ,American ,Mary Anne Heino ,Dakota Investment Council ,Lantheus Holdings Inc ,Silverberg Bernstein Capital Management ,Lantheus Alpha Therapy Llc ,American Century Companies Inc ,Get Free Report ,Truist Financial ,Trading Down ,Director Mary Anne Heino ,Lantheus Alpha Therapy ,Bernstein Capital Management ,Century Companies ,Boston Partners ,Lantheus Daily ,Lantheus ,Nasdaq Lnth ,Lnth ,Medical ,Boost Price Target ,Truist Financial Co ,